These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10495006)

  • 1. Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice.
    Rodríguez-Arias M; Pinazo J; Miñarro J; Stinus L
    Pharmacol Biochem Behav; 1999 Sep; 64(1):123-30. PubMed ID: 10495006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H; Gerlach J; Peacock L
    Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166.
    Prinssen EP; Ellenbroek BA; Stamatovic B; Cools AR
    Eur J Pharmacol; 1993 Feb; 231(2):275-80. PubMed ID: 8095900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of morphine and haloperidol on agonistic and motor behaviors of male mice.
    Rodríguez-Arias M; Miñarro J; Simón VM
    Pharmacol Biochem Behav; 1997 Sep; 58(1):153-8. PubMed ID: 9264084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
    Brent PJ; Chahl LA
    Eur Neuropsychopharmacol; 1993 Mar; 3(1):23-32. PubMed ID: 8097127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
    Robertson GS; Fibiger HC
    Neuroscience; 1992; 46(2):315-28. PubMed ID: 1347406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates.
    Elwan MA; Soliman MR
    Pharmacology; 1995 Aug; 51(2):73-83. PubMed ID: 8584575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the role of dopamine D1 receptors in morphine induced stereotypic behavior.
    Pollock J; Kornetsky C
    Neurosci Lett; 1989 Jul; 102(2-3):291-6. PubMed ID: 2682389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm.
    Didriksen M
    Eur J Pharmacol; 1995 Aug; 281(3):241-50. PubMed ID: 8521906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
    Salmi P; Malmgren K; Svensson TH; Ahlenius S
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):593-9. PubMed ID: 9686934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH
    Eur J Pharmacol; 1988 Jan; 146(1):113-20. PubMed ID: 2895008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors.
    Bo P; Ongini E; Giorgetti A; Savoldi F
    Neuropharmacology; 1988 Aug; 27(8):799-805. PubMed ID: 2905785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.
    Shen EH; Crabbe JC; Phillips TJ
    Psychopharmacology (Berl); 1995 Mar; 118(1):28-36. PubMed ID: 7597119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the EEG profile of neuroleptics selective for D-1 or D-2 dopamine receptors in the rabbit.
    Bo P; Savoldi F
    Pharmacol Res; 1992; 26(1):67-74. PubMed ID: 1387476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Farzin D
    Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit.
    Bo P; Marchioni E; Dallocchio C; Albergati A; Savoldi F
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):803-15. PubMed ID: 1837158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment.
    Peacock L; Lublin H; Gerlach J
    Eur J Pharmacol; 1990 Sep; 186(1):49-59. PubMed ID: 1980891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
    Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
    Rezayat M; Azizi N; Zarrindast MR
    Pharmacol Toxicol; 1997 Sep; 81(3):124-9. PubMed ID: 9335069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.